Crossmark

The role of rapid onset fentanyl products in the management of breakthrough pain in cancer patients

Crossref DOI link: https://doi.org/10.1016/j.pharep.2019.01.010

Published Print: 2019-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Brząkała, Joanna

Leppert, Wojciech
License Information

Text and Data Mining valid from 2019-06-01
More Information

This article is maintained by: Elsevier

Article Title: The role of rapid onset fentanyl products in the management of breakthrough pain in cancer patients

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2019.01.010

Content Type: article

Copyright: © 2019 Published by Elsevier B.V. on behalf of Institute of Pharmacology, Polish Academy of Sciences.